100 drugs in pipeline from 10 companies
100
Drugs in Pipeline
10
Companies
7
Upcoming Catalysts
72
Phase 3 Trials
XEN1101 Phase 3 Results Expected
XEN1101 • Primary Generalized Tonic-Clonic Seizures
Placebo Phase 3 Results Expected
Placebo • Psychosis Associated With Alzheimer's Disease
Fasedienol Nasal Spray Phase 3 Results Expected
Fasedienol Nasal Spray • Social Anxiety Disorder (SAD)
Fasedienol Nasal Spray - Placebo Nasal Spray Phase 2 Results Expected
Fasedienol Nasal Spray - Placebo Nasal Spray • Social Anxiety Disorder
Placebo Phase 3 Results Expected
Placebo • Psychosis Associated With Alzheimer's Disease
SUPERNUS PHARMACEUTICALS, INC.
DiaMedica Therapeutics Inc.
Kyowa Kirin Co., Ltd.
Eli Lilly and Company
Johnson & Johnson
Intra-Cellular Therapies, Inc.
Xenon Pharmaceuticals Inc.
Sanofi
Eisai Co., Ltd.
Astellas Pharma Inc.
